To investigate if IGF-IR signaling pathway effectors and YAP1 are co-regulated in MLS development, we analyzed the expression of IGF-II, IGF-IR, and YAP1 in tumor specimens from 54 MLS patients using IHC (Fig. 1A). The gene discussed is YAP1; the disease is neoplasm.